Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GB001 in moderate to severe asthma
NCT03683576Phase 2Completed
- Sponsor
- Gossamer Bio
- Start
- Oct 2018
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of GB001 in asthma, sponsored by Gossamer Bio. Started Oct 2018; status: completed.
02
Drugs
GB001
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03683576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03683576.